Edgewise Therapeutics Inc (NAS:EWTX)
$ 43.07 +1.135 (+2.71%) Market Cap: 4.68 Bil Enterprise Value: 4.22 Bil PE Ratio: 0 PB Ratio: 10.35 GF Score: 28/100

Edgewise Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 09:30PM GMT
Release Date Price: $26.67 (-0.41%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Hey, good afternoon, everyone. Welcome to the 5:30 session on day 2 at the 42nd Annual Global Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh, and I cover U.S. and European biopharma here at the firm. It's a great pleasure of mine to be able to host Edgewise Therapeutics today in a fireside chat. And with me, we've got 3 members of the management team: Kevin Koch, CEO of the company; Alan Russell, Chief Scientific Officer; and Behrad Derakhshan, who is the Chief Business Officer. So with that, I want to welcome the 3 of you, and thanks for joining.

Kevin Koch
Edgewise Therapeutics, Inc. - President, CEO & Director

No, thank you.

Behrad Derakhshan
Edgewise Therapeutics, Inc. - Chief Business Officer

Thanks, Graig.

Kevin Koch
Edgewise Therapeutics, Inc. - President, CEO & Director

It's great to be involved.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot